Peng Xu
Affiliations: | 2014 | East Asian Languages and Civilizations | University of Chicago, Chicago, IL |
Google:
"Peng Xu"Parents
Sign in to add mentorJudith Zeitlin | grad student | 2014 | Chicago | |
(Lost sound: Singing, theater, and aesthetics in late Ming China, 1547-1644) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wong GS, Zhou J, Liu JB, et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nature Medicine |
Henderson L, Xu P, O'Day E, et al. (2016) KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal adenocarcinoma. Journal of Clinical Oncology. 34: 4065-4065 |
Chapman CG, Catenacci DV, Xu P, et al. (2016) 1106 EUS Acquired Portal Venous Circulating Tumor Cells (PV-CTCs) May Provide Prognostic Assistance in Pancreaticobiliary Cancers Gastroenterology. 150 |
Catenacci DV, Liao WL, Zhao L, et al. (2015) Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association |
Catenacci DVT, Tang R, Oliner KS, et al. (2015) MET as a prognostic biomarker of survival in a large cohort of patients with gastroesophageal cancer (GEC). Journal of Clinical Oncology. 33: 4034-4034 |
Catenacci DV, Liao WL, Thyparambil S, et al. (2014) Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue. Plos One. 9: e100586 |
Catenacci DVT, Polite BN, Henderson L, et al. (2014) Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity—PANGEA. Journal of Clinical Oncology. 32: 66-66 |
Hembrough TA, Henderson L, Rambo B, et al. (2014) Quantification of HER2 from gastroesophageal cancer (GEC) FFPE tissue by mass spectrometry (MS). Journal of Clinical Oncology. 32: 17-17 |
Hembrough TA, Liao W, Thyparambil S, et al. (2014) Quantification of MET expression using mass spectrometry (MS): Assay precision and stability in FFPE tumor tissue. Journal of Clinical Oncology. 32: 16-16 |
Cecchi F, Liao W, Thyparambil S, et al. (2014) 537 Absolute quantitation of MET using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue European Journal of Cancer. 50: 175 |